ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Thursday, 12 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Earnings Call

Chandan Healthcare Earnings Call: Key Takeaways

Chandan Healthcare reported strong FY26 performance with Revenue of ₹280.67 Cr and PAT of ₹27.06 Cr, driven by network expansion and strategic PPP projects.

Highlights
Revenue growth20.43% YoY for FY26.
MarginsFY26 EBITDA margin improved to 20.25% from 18.62%.
Order bookEstimated Punjab PPP project value of ₹25–26 Cr.
Demand visibilityStrong visibility via 10-year government PPP contracts.
Management confidenceHigh, citing strong network growth and strategic partnerships.

Growth

FY26 revenue grew 20.43% YoY to ₹280.67 Cr; EBITDA rose 31.02% to ₹56.84 Cr with margins expanding to 20.25%.

Outlook

Targeting 100 labs across 17 states in 3 years; planning 20+ new medical centres annually.

Risks

Subject to Indian economic performance, competition in diagnostics, and technological changes.

Source

Earnings Call filed with NSE, NSE: CHANDAN. Summary written with AI assistance from the document.

Read the document ↗

Chandan Healthcare Ltd: key numbers

Share price
₹238.00
Market cap
₹611.7 Cr
Revenue (annual)
₹276.4 Cr
Net profit (annual)
₹27.06 Cr
P/E (TTM)
22.6×Sector 54.5×
Promoter holding
47.20%-2.41% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Chandan Healthcare Ltd

All →